Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:187-193
Published online before print November 1, 2007, doi: 10.1161/ATVBAHA.107.154989
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/1/187    most recent
ATVBAHA.107.154989v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohty, D.
Right arrow Articles by Mathieu, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohty, D.
Right arrow Articles by Mathieu, P.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:187.)
© 2008 American Heart Association, Inc.


Clinical and Population Studies

Association Between Plasma LDL Particle Size, Valvular Accumulation of Oxidized LDL, and Inflammation in Patients With Aortic Stenosis

Dania Mohty; Philippe Pibarot; Jean-Pierre Després; Claude Côté; Benoit Arsenault; Amélie Cartier; Pierre Cosnay; Christian Couture; Patrick Mathieu

From the Laboratoire d’Études Moléculaires des Valvulopathies (LEMV) (D.M., C. Côté, P.M.), Groupe de Recherche en Valvulopathies (GRV), Laval Hospital Research Center/Quebec Heart Institute, Department of Surgery, Laval University, Quebec, Canada; the Department of Medicine (D.M., P.P.), Laval University, Quebec, Canada; the Division of Kinesiology (J.-P.D., B.A., A.C.), Department of Social and Preventive Medicine, Laval University, Québec, Canada; UMR CNRS 6542 (P.C.), Université François Rabelais, Tours, France; and the Department of Pathology (C. Couture), Laval Hospital, Quebec, Canada.

Correspondence to Dr Patrick Mathieu, Laval Hospital, 2725 Chemin Ste-Foy, Quebec, Canada, G1V-4G5. E-mail patrick.mathieu{at}chg.ulaval.ca

Abstract

Objective— In patients with severe aortic stenosis (AS), we examine the association between: (1) the content of oxidized LDL (oxLDL) in the aortic valve and the degree of inflammation and remodeling; (2) The proportion of small dense LDL particles in the plasma and the presence of oxLDL in the valve along with hemodynamic progression of valve stenosis.

Methods and Results— We have examined 102 explanted AS valves. Tissue remodeling, inflammation, and accumulation of oxLDL were determined. A complete plasma lipid profile including the measurement of the relative proportion of small low-density lipoprotein (%LDL<255Å) was obtained. Valves with higher oxLDL content had a significantly higher density of inflammatory cells, expression of tumor necrosis factor (TNF)-{alpha}, and increased tissue remodeling score. The %LDL<255Å was significantly associated with oxLDL score within the aortic valve. In a subset of 59 patients in whom stenosis progression was measured, the %LDL<255Å correlated with the annualized peak gradient (r=0.29; P=0.04).

Conclusion— Increased proportion of circulating small dense LDL particles is associated with faster progression rate of stenosis and greater accumulation of oxLDL in the aortic valve. These findings suggest that therapeutic interventions aimed at lowering the production of small dense LDL particles in patients with AS might represent a potentially interesting therapeutic avenue.

In 102 aortic valves explanted for a stenosis, we found that valves with a higher content of oxidized LDL had more pronounced inflammation and tissue remodeling. The proportion of circulating small dense LDL particles was associated with valvular accumulation of oxidized LDL and faster progression of stenosis.


Key Words: aortic stenosis • oxidized low-density lipoproteins • small size low-density lipoprotein particles




This article has been cited by other articles:


Home page
Therapeutic Advances in Cardiovascular DiseaseHome page
A. M. Greve and K. Wachtell
Review: Does lowering cholesterol have an impact on the progression of aortic stenosis?
Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 277 - 286.
[Abstract] [PDF]


Home page
J. Lipid Res.Home page
S. Helske, T. Miettinen, H. Gylling, M. Mayranpaa, J. Lommi, H. Turto, K. Werkkala, M. Kupari, and P. T. Kovanen
Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves
J. Lipid Res., July 1, 2008; 49(7): 1511 - 1518.
[Abstract] [Full Text] [PDF]